Short-term effects of atorvastatin on haemorheologic parameters, platelet aggregation and endothelium dysfunction in patients with hypercholesterolaemia.
Horvath
Beata
B
Marton
Zsolt
Z
Alexy
Tamas
T
Kesmarky
Gabor
G
Toth
Kalman
K
Szapary
Laszlo
L
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000941:Antigens / Q000378:metabolism; D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood*; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D011758:Pyrroles / Q000627:therapeutic use*; D014841:von Willebrand Factor / Q000276:immunology
D000924:Anticholesteremic Agents; D000941:Antigens; D006538:Heptanoic Acids; D011758:Pyrroles; C029417:Von Willebrand antigen; D014841:von Willebrand Factor; D002784:Cholesterol; D000069059:Atorvastatin